Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Optimizing parametrial aperture design utilizing HDR brachytherapy isodose distribution.

Chapman KL, Ohri N, Showalter TN, Doyle LA.

J Contemp Brachytherapy. 2013 Mar;5(1):50-4. doi: 10.5114/jcb.2013.34341. Epub 2013 Mar 29.

2.
4.

Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.

Kini VR, Edmundson GK, Vicini FA, Jaffray DA, Gustafson G, Martinez AA.

Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):571-8. Review.

PMID:
10078639
5.

Comparative dosimetric and radiobiological assessment among a nonstandard RapidArc, standard RapidArc, classical intensity-modulated radiotherapy, and 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecologic cancer.

Pedicini P, Caivano R, Fiorentino A, Strigari L, Califano G, Barbieri V, Sanpaolo P, Castaldo G, Benassi M, Fusco V.

Med Dosim. 2012 Winter;37(4):347-52. doi: 10.1016/j.meddos.2011.11.009. Epub 2012 Mar 3.

PMID:
22382087
6.

Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer.

Kestin LL, Martinez AA, Stromberg JS, Edmundson GK, Gustafson GS, Brabbins DS, Chen PY, Vicini FA.

J Clin Oncol. 2000 Aug;18(15):2869-80.

PMID:
10920135
7.

Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy?

Morton GC, Hoskin PJ.

Clin Oncol (R Coll Radiol). 2013 Aug;25(8):474-82. doi: 10.1016/j.clon.2013.04.009. Epub 2013 May 30. Review.

PMID:
23727431
8.

Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.

Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.

Cancer. 2009 Dec 1;115(23):5596-606. doi: 10.1002/cncr.24558.

10.

Rapid involution and mobility of carcinoma of the cervix.

Lee CM, Shrieve DC, Gaffney DK.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):625-30.

PMID:
14751536
11.

The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.

Lee YC, Rash DL, Stern RL, Mayadev JS.

Brachytherapy. 2013 Nov-Dec;12(6):555-9. doi: 10.1016/j.brachy.2013.06.002. Epub 2013 Jul 20.

PMID:
23880417
12.

Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.

Ishiyama H, Kitano M, Satoh T, Kotani S, Uemae M, Matsumoto K, Okusa H, Tabata K, Baba S, Hayakawa K.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):23-8. doi: 10.1016/j.ijrobp.2008.11.006. Epub 2009 Feb 23.

PMID:
19243900
13.

Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.

Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M 3rd, Phillips T.

Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):851-8.

PMID:
10705005
14.

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):343-52.

PMID:
10802358
15.

Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.

Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, Gustafson G, Ye H, Martinez A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):204-12. doi: 10.1016/j.ijrobp.2010.10.009. Epub 2010 Dec 16.

PMID:
21167653
16.

3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer.

Martin T, Röddiger S, Kurek R, Dannenberg T, Eckart O, Kolotas C, Heyd R, Rogge B, Baltas D, Tunn U, Zamboglou N.

Radiother Oncol. 2004 Apr;71(1):35-41.

PMID:
15066294
17.

Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.

Mohamed S, Kallehauge J, Fokdal L, Lindegaard JC, Tanderup K.

Brachytherapy. 2015 Jan-Feb;14(1):23-8. doi: 10.1016/j.brachy.2014.09.010. Epub 2014 Nov 8.

PMID:
25455382
18.
19.

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer.

Kazi A, Godwin G, Simpson J, Sasso G.

BMC Cancer. 2010 Sep 1;10:472. doi: 10.1186/1471-2407-10-472.

20.

Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.

Ozyar E, Yildz F, Akyol FH, Atahan IL.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):101-8.

PMID:
11777627

Supplemental Content

Support Center